Oncotelic Therapeutics, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Oncotelic Therapeutics, Inc. (OTLC) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.10 per share for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2024-04-12
- Oncotelic Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2017-03-31 was $0.40, a 45.21% decline year-over-year.
- Oncotelic Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2016-03-31 was $0.73, a 58.05% decline year-over-year.
- Oncotelic Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2015-03-31 was $1.74, a 36.50% decline year-over-year.
- Oncotelic Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2014-03-31 was $2.74, a 37.44% decline year-over-year.
- Oncotelic Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $0.10, a 33.33% decline from fiscal 2021.
- Oncotelic Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $0.15.
- Oncotelic Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2018 was $0.22, a 47.62% decline from fiscal 2017.
- Oncotelic Therapeutics, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2017 was $0.42, a 40.00% decline from fiscal 2016.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $0.10 10-K · filed 2024-04-12 | ||||
| 2022-09-30 | $0.10 10-Q · filed 2023-11-14 | ||||
| 2021-12-31 | $0.15 10-K/A · filed 2023-04-20 | ||||
| 2021-09-30 | $0.15 10-Q · filed 2021-11-22 | ||||
| 2018-12-31 | $0.22 10-K · filed 2019-04-10 | ||||
| 2018-09-30 | $0.22 10-Q · filed 2018-11-14 | ||||
| 2018-06-30 | $0.22 10-Q · filed 2018-08-14 | ||||
| 2017-12-31 | $0.42 10-K · filed 2019-04-10 | ||||
| 2017-09-30 | $0.42 10-Q · filed 2017-11-14 | ||||
| 2017-06-30 | $0.42 10-Q · filed 2017-08-02 | ||||
| 2017-03-31 | $0.40 10-Q · filed 2017-05-08 | ||||
| 2016-12-31 | $0.70 10-K · filed 2018-04-17 | ||||
| 2016-09-30 | $0.72 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | $0.72 10-Q · filed 2016-08-02 | ||||
| 2016-03-31 | $0.73 10-Q · filed 2016-05-06 | ||||
| 2015-12-31 | $1.95 10-K · filed 2017-03-30 | $1.40 10-K · filed 2016-03-25 | |||
| 2015-09-30 | $1.41 10-Q · filed 2015-11-12 | ||||
| 2015-06-30 | $1.44 10-Q · filed 2015-08-06 | ||||
| 2015-03-31 | $1.74 10-Q · filed 2015-05-07 | ||||
| 2014-12-31 | $2.67 10-K · filed 2016-03-25 | ||||
| 2014-09-30 | $2.73 10-Q · filed 2014-11-13 | ||||
| 2014-06-30 | $2.77 10-Q · filed 2014-08-08 | ||||
| 2014-03-31 | $2.74 10-Q · filed 2014-05-08 | ||||
| 2013-12-31 | $3.90 10-K · filed 2015-03-30 | ||||
| 2013-09-30 | $3.90 10-Q · filed 2013-11-13 | ||||
| 2013-06-30 | $4.38 10-Q/A · filed 2013-10-18 | ||||
| 2013-03-31 | $4.38 10-Q · filed 2013-05-09 | ||||
| 2012-12-31 | $9.83 10-K · filed 2015-03-30 | ||||
| 2012-09-30 | $0.82 10-Q · filed 2012-11-09 | ||||
| 2012-06-30 | $1.07 10-Q · filed 2012-08-13 | ||||
| 2011-12-31 | $12.62 10-K · filed 2014-03-20 | ||||
| 2010-12-31 | $194.30 10-K · filed 2013-03-15 |